Search
Ropidoxuridine
go.drugbank.com/drugs/DB06485InvestigationalRopidoxuridine is a novel, orally available, thymidine analogue and prodrug for IUdR, which demonstrated a survival advantage in Phase II studies in anaplastic astrocytoma, a type of brain tumor.
Eritoran
go.drugbank.com/drugs/DB04933InvestigationalIt is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.
Solanezumab
go.drugbank.com/drugs/DB11756InvestigationalSolanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
NXC680
go.drugbank.com/drugs/DB18366ExperimentalNXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).
Glucagon-like peptide II
go.drugbank.com/drugs/DB12788InvestigationalGlucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.
Urocortin-2
go.drugbank.com/drugs/DB13033InvestigationalUrocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
Pimonidazole
go.drugbank.com/drugs/DB12485InvestigationalPimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer.
FLX475
go.drugbank.com/drugs/DB15570InvestigationalFLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875]
EVT 201
go.drugbank.com/drugs/DB05721InvestigationalEVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.